Agoracom: Small Cap Investment

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Top-Line Results for Phase 3 BETonMACE Cardio Outcomes Trial were Announced September 30, 2019

Free

latest 24 hours

24

Sep 26, 2019 08:38AM

Apabetalone and Alkaline Phosphatase

18

Oct 12, 2019 08:31AM

Re: So BETonMACE failed the primary endpoint. What's next?

17

Sep 30, 2019 05:24PM

So BETonMACE failed the primary endpoint. What's next?

16

Sep 30, 2019 05:16PM

Re: So BETonMACE failed the primary endpoint. What's next?

15

Oct 01, 2019 10:30AM

Re: Can anyone say....

14

Sep 24, 2019 07:44PM

The synergy of rosuvastatin (Crestor) with apabetalone

12

Oct 03, 2019 08:23AM

Re: Resverlogix Announces Topline Results in BETonMACE Phase 3 Epigenetics Trial

12

Danceswithorses

Sep 30, 2019 10:44AM

12

Oct 01, 2019 03:56PM

Re: Back to the FDA

11

Oct 04, 2019 06:54AM